A carregar...

Is phosphoadenosine phosphate phosphatase a target of lithium’s therapeutic effect?

Lithium, which is approved for treating patients with bipolar disorder, is reported to inhibit 3′(2′)-phosphoadenosine-5′-phosphate (PAP) phosphatase activity. In yeast, deletion of PAP phosphatase results in elevated PAP levels and in inhibition of sulfation and of growth. The effect of lithium on...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Shaltiel, G., Deutsch, J., Rapoport, S. I, Basselin, M., Belmaker, R. H., Agam, G.
Formato: Artigo
Idioma:Inglês
Publicado em: 2009
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2966591/
https://ncbi.nlm.nih.gov/pubmed/19756369
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00702-009-0298-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!